by Dr Khan | Feb 4, 2021 | Uncategorized
Monoclonal antibodies (mAbs) against SARS-CoV-2 spike protein show promise in phase 3 clinical trials for the treatment and prevention of COVID-19 Emergency use authorizations (EUAs) for treatment approved for: ambulatory patients with mild to moderate...
by Dr Khan | Jan 21, 2021 | Uncategorized
December is typically busy in the ICU. Flu and respiratory viral pneumonia cases start trickling into the ICU, interspersed with cardiac arrests, strokes, pulmonary emboli, septic shock, and COPD exacerbations. The ICU census starts creeping up. December 2020 has been...
by Dr Khan | Dec 20, 2020 | Uncategorized
Timeline of the two mRNA COVID-19 vaccines Dec 10: Vaccine and Biological Products Advisory Committee (VRBPAC) voted to recommend FDA emergency use authorization (EUA) of the Pfizer-BioNTech Vaccine for the prevention of COVID-19 in persons aged 16 or older Dec 11:...
by Dr Khan | Nov 30, 2020 | Uncategorized
On November 30th, 2020, according to the CDC tracker the total number of COVID-19 cases in the USA is 13, 295 605, new case per 100k in the last 7 days are 48.9, and 266,051 total deaths. I am a critical care doc. I am at the frontlines of this pandemic, in a...
by Dr Khan | Oct 29, 2020 | Uncategorized
Lung cancer screening is a process that is used to detect the presence of lung cancer in otherwise healthy people at high risk for cancer. In 2020, 229,000 people will be diagnosed with lung cancer and 136,000 people will die from the disease making it the leading...
Recent Comments